英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：

alveus    
海马神经纤维

海马神经纤维


请选择你想看的字典辞典：
单词字典翻译
alveus查看　alveus　在百度字典中的解释百度英翻中〔查看〕
alveus查看　alveus　在Google字典中的解释Google英翻中〔查看〕
alveus查看　alveus　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Home - Alveus Therapeutics
    Alveus’s pipeline is focused on next-generation metabolic therapies; the lead asset ALV-100 is currently in Phase 2 The company’s preclinical amylin pipeline consists of best-in-class peptides, oral small molecules, and other novel formats targeting improved quality of weight loss
  • Alveus Sanctuary - Wikipedia
    Higa announced an expansion of Alveus Sanctuary into the Alveus Research Recovery Institute (ARRI) on October 19, 2025 The Institute will focus on conservation breeding programs for Red Wolves and Mexican Gray Wolves, which are critically endangered
  • Alveus | Premium Tea Wholesaler For Businesses
    Alveus tea wholesaler Discover the largest variety of teas and infusions with organic certification in the world Request your catalogue!
  • Alveus Therapeutics Launches with $160 Million Series A . . . - BioSpace
    With world-class investors and a team that has repeatedly brought metabolic medicines from concept to commercialization, Alveus is well positioned to lead the next wave of innovation in obesity therapeutics
  • Alveus launches with $160M to advance MariTide-like obesity drug
    Alveus launches with $160M to advance MariTide-like obesity drug The hefty funding will fuel Phase 2 testing of a drug with a similar mechanism to Amgen’s closely watched obesity drug, as well as an amylin-targeting weight loss medicine
  • Equipped with $160M series A, Alveus debuts into crowded obesity . . .
    Looking to overcome some of the limitations of existing obesity drugs, Alveus Therapeutics has debuted with nearly $160 million in hand and an impressive roster of executives ready to take the
  • Alveus Therapeutics Inc - LinkedIn
    Alveus Therapeutics is a clinical-stage biotechnology company developing next-generation therapies for obesity and metabolic diseases, designed for sustained efficacy, improved tolerability, and
  • Biotech Alveus raises $160 million to tackle weight loss maintenance
    Alveus is also developing ALV-200, a selective amylin-based therapy that has entered the regulatory filing stage and is designed to preserve lean muscle during weight loss





中文字典-英文字典  2005-2009